Forte Biosciences Inc (FBRX)

$27.46 +0.72 (2.69%)
Market Cap 334.97M
Revenue (ttm) 0.00
Net Income (ttm) -35.48M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 152,600
Avg Vol 214,688
Day's Range N/A - N/A
Shares Out 12.53M
Stochastic %K 21%
Beta 3.24
Analysts Strong Sell
Price Target $63.75

Company Profile

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

Industry: Biotechnology
Sector: Healthcare
Phone: 310 618 6994
Address:
3060 Pegasus Park Drive, Building 6, Dallas, United States
porky1963
porky1963 Mar. 13 at 7:48 AM
$FBRX small decline in fbrx value,not a suprise as eveything connected to trouble in the gulf .long turn mind,looking at 3-5 years for big gains so hanging in for long turn and will purchase a few in a dip.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 13 at 2:18 AM
$FBRX RSI: 40.00, MACD: -0.4142 Vol: 1.35, MA20: 29.42, MA50: 29.50 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
StormTitan
StormTitan Mar. 11 at 12:12 PM
$FBRX when 40$
0 · Reply
porky1963
porky1963 Mar. 10 at 9:01 AM
$FBRX up today,news soon,hope its good.
0 · Reply
gippermac
gippermac Mar. 5 at 3:29 PM
$FBRX
0 · Reply
InfernoWyrm
InfernoWyrm Feb. 27 at 6:25 PM
•@SqueezeSharkie is operating on a whole different level, easily ahead of 90% of the traders on this platform. If you’re not paying attention yet, you’re missing out. Go give him a follow it’s completely free and only takes a second 💎 $SM $BRLS $BYAH $FBRX •,• on watch
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 27 at 12:34 PM
$FBRX RSI: 51.91, MACD: -0.0567 Vol: 1.86, MA20: 30.02, MA50: 28.96 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
porky1963
porky1963 Feb. 26 at 8:04 AM
$FBRX fancy it being a treasure chest then,its got a long way to go but you never know.its holding well with a big volume so lets hang on,crypto takeing a big blow,gold far to expensive,oil stable .inflation steady for now.saveing rates low.if you got in at $5 at its low you realy done well.__
0 · Reply
porky1963
porky1963 Feb. 24 at 11:25 AM
$FBRX guess we are in the UP+DOWN zone.well i have done very well so far and will be here for the long run,there are meetings next month letts be hopefull of good reports i cant see why not.
0 · Reply
InfernoWyrm
InfernoWyrm Feb. 17 at 7:03 PM
$WELL $FBRX $CRI $KVHI \|\|\
0 · Reply
Latest News on FBRX
Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules

Mar 4, 2026, 4:01 PM EST - 12 days ago

Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules

Forte Biosciences, Inc. to Present at Upcoming Investor Meetings

Feb 9, 2026, 4:01 PM EST - 5 weeks ago

Forte Biosciences, Inc. to Present at Upcoming Investor Meetings

Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules

Dec 22, 2025, 4:01 PM EST - 3 months ago

Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules

Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update

Nov 14, 2025, 9:00 AM EST - 4 months ago

Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update

Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences

Nov 3, 2025, 4:01 PM EST - 4 months ago

Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences

Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules

Oct 3, 2025, 4:01 PM EDT - 5 months ago

Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules

Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease Symposium

Sep 15, 2025, 9:00 AM EDT - 6 months ago

Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease Symposium

Forte Biosciences, Inc. Announces Results and Provides Update

Aug 14, 2025, 4:01 PM EDT - 7 months ago

Forte Biosciences, Inc. Announces Results and Provides Update

Forte Biosciences Announces Pricing of $75 Million Public Offering

Jun 25, 2025, 12:28 AM EDT - 9 months ago

Forte Biosciences Announces Pricing of $75 Million Public Offering

Forte Biosciences Announces Proposed Public Offering

Jun 24, 2025, 4:01 PM EDT - 9 months ago

Forte Biosciences Announces Proposed Public Offering

Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study

Jun 23, 2025, 7:18 AM EDT - 9 months ago

Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study

Forte Biosciences, Inc. Announces Results and Provides Clinical Update

Mar 31, 2025, 9:00 AM EDT - 1 year ago

Forte Biosciences, Inc. Announces Results and Provides Clinical Update

Forte Biosciences to Host R&D Day December 3, 2024

Nov 25, 2024, 9:00 AM EST - 1 year ago

Forte Biosciences to Host R&D Day December 3, 2024

Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications

Nov 20, 2024, 9:00 AM EST - 1 year ago

Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications

Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update

Nov 14, 2024, 4:01 PM EST - 1 year ago

Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update

Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update

Aug 14, 2024, 4:01 PM EDT - 1 year ago

Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update

Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update

May 13, 2024, 4:05 PM EDT - 2 years ago

Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update

Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update

Mar 18, 2024, 4:05 PM EDT - 2 years ago

Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update

Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update

Nov 13, 2023, 4:01 PM EST - 2 years ago

Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update

ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company's Upcoming Annual Meeting

Sep 14, 2023, 10:50 AM EDT - 2 years ago

ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company's Upcoming Annual Meeting

Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company's Boardroom

Sep 6, 2023, 3:15 PM EDT - 2 years ago

Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company's Boardroom

Concerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to Stockholders

Aug 25, 2023, 8:00 AM EDT - 2 years ago

Concerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to Stockholders

Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update

Aug 14, 2023, 4:01 PM EDT - 2 years ago

Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update

Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102

Aug 1, 2023, 4:01 PM EDT - 2 years ago

Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102

Forte Biosciences, Inc. Announces First Quarter 2023 Results and Provides Business Update

May 15, 2023, 4:01 PM EDT - 3 years ago

Forte Biosciences, Inc. Announces First Quarter 2023 Results and Provides Business Update

Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update

Mar 31, 2023, 4:05 PM EDT - 3 years ago

Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update

Mr. David Gryska Appointed to Forte Biosciences Board of Directors

Jan 12, 2023, 4:05 PM EST - 3 years ago

Mr. David Gryska Appointed to Forte Biosciences Board of Directors

Dr. Scott Brun, M.D. Appointed to Forte Biosciences Board of Directors

Nov 14, 2022, 4:01 PM EST - 3 years ago

Dr. Scott Brun, M.D. Appointed to Forte Biosciences Board of Directors

Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update

Nov 14, 2022, 4:01 PM EST - 3 years ago

Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update

Camac Partners Condemns Forte Biosciences' Seemingly Defensive and Unjustifiable Capital Raise

Aug 17, 2022, 8:00 AM EDT - 3 years ago

Camac Partners Condemns Forte Biosciences' Seemingly Defensive and Unjustifiable Capital Raise

Forte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update

Aug 15, 2022, 4:05 PM EDT - 3 years ago

Forte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update

Forte Biosciences, Inc. Announces the Appointment of Dr. Hubert Chen, MD as Chief Scientific Officer and President

Jun 7, 2022, 9:00 AM EDT - 4 years ago

Forte Biosciences, Inc. Announces the Appointment of Dr. Hubert Chen, MD as Chief Scientific Officer and President

Forte Biosciences, Inc. Announces First Quarter 2022 Results and Provides Business Update

May 16, 2022, 9:00 AM EDT - 4 years ago

Forte Biosciences, Inc. Announces First Quarter 2022 Results and Provides Business Update

INVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Forte Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm

Sep 6, 2021, 12:42 PM EDT - 4 years ago

INVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Forte Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm

Why Forte Biosciences Stock Is Down Over 80% Today

Sep 3, 2021, 2:31 PM EDT - 4 years ago

Why Forte Biosciences Stock Is Down Over 80% Today

A small biotech firm just plummeted 82% after abandoning a drug candidate due to failed phase 2 trial

Sep 3, 2021, 12:19 PM EDT - 4 years ago

A small biotech firm just plummeted 82% after abandoning a drug candidate due to failed phase 2 trial

Forte Biosciences stock plunges more than 80% after 'disappointing' trial results of atopic dermatitis treatment

Sep 3, 2021, 7:21 AM EDT - 4 years ago

Forte Biosciences stock plunges more than 80% after 'disappointing' trial results of atopic dermatitis treatment

Forte Biosciences Just Plummeted 80%: Here's Why

Sep 2, 2021, 5:47 PM EDT - 4 years ago

Forte Biosciences Just Plummeted 80%: Here's Why

Clinical Trial of FB-401 For the Treatment of Atopic Dermatitis Fails to Meet Statistical Significance

Sep 2, 2021, 4:05 PM EDT - 4 years ago

Clinical Trial of FB-401 For the Treatment of Atopic Dermatitis Fails to Meet Statistical Significance

Forte Biosciences, Inc. to Review the Second Quarter 2021 Results and Expects to Announce Topline Data From Phase 2 Clinical Trial of FB-401 for the Treatment of Atopic Dermatitis on Sept. 7

Aug 16, 2021, 4:05 PM EDT - 4 years ago

Forte Biosciences, Inc. to Review the Second Quarter 2021 Results and Expects to Announce Topline Data From Phase 2 Clinical Trial of FB-401 for the Treatment of Atopic Dermatitis on Sept. 7

Forte Biosciences, Inc. (FBRX) CEO Paul Wagner on Q1 2021 Results - Earnings Call Transcript

May 11, 2021, 7:24 AM EDT - 5 years ago

Forte Biosciences, Inc. (FBRX) CEO Paul Wagner on Q1 2021 Results - Earnings Call Transcript

Forte Biosciences, Inc. Announces First Quarter 2021 Results and Provides a General Business Update

May 10, 2021, 4:05 PM EDT - 5 years ago

Forte Biosciences, Inc. Announces First Quarter 2021 Results and Provides a General Business Update

Forte Biosciences, Inc. to Announce First Quarter 2021 Results and Provide a General Business Update

May 3, 2021, 4:30 PM EDT - 5 years ago

Forte Biosciences, Inc. to Announce First Quarter 2021 Results and Provide a General Business Update

Forte Biosciences: Microbiome Therapeutics For Skin Disease

Apr 9, 2021, 6:07 AM EDT - 5 years ago

Forte Biosciences: Microbiome Therapeutics For Skin Disease

Forte Biosciences: FB-401 Could Become The First Line Topical Therapy In Atopic Dermatitis Market

Apr 8, 2021, 6:59 PM EDT - 5 years ago

Forte Biosciences: FB-401 Could Become The First Line Topical Therapy In Atopic Dermatitis Market

Week 13 MDA Breakout Stocks - April 2021: Short-Term Picks To Give You An Edge

Mar 29, 2021, 12:10 PM EDT - 5 years ago

Week 13 MDA Breakout Stocks - April 2021: Short-Term Picks To Give You An Edge

AMGN AXP CAT IMOM JPM UNH VRA

Forte Biosciences, Inc. Announces 4Q and Full Year 2020 Results and Provides a General Business Update

Mar 24, 2021, 8:00 AM EDT - 5 years ago

Forte Biosciences, Inc. Announces 4Q and Full Year 2020 Results and Provides a General Business Update

Forte Biosciences, Inc. to Announce 4Q and Full Year 2020 Results and Provide a General Business Update

Mar 17, 2021, 4:05 PM EDT - 5 years ago

Forte Biosciences, Inc. to Announce 4Q and Full Year 2020 Results and Provide a General Business Update

porky1963
porky1963 Mar. 13 at 7:48 AM
$FBRX small decline in fbrx value,not a suprise as eveything connected to trouble in the gulf .long turn mind,looking at 3-5 years for big gains so hanging in for long turn and will purchase a few in a dip.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 13 at 2:18 AM
$FBRX RSI: 40.00, MACD: -0.4142 Vol: 1.35, MA20: 29.42, MA50: 29.50 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
StormTitan
StormTitan Mar. 11 at 12:12 PM
$FBRX when 40$
0 · Reply
porky1963
porky1963 Mar. 10 at 9:01 AM
$FBRX up today,news soon,hope its good.
0 · Reply
gippermac
gippermac Mar. 5 at 3:29 PM
$FBRX
0 · Reply
InfernoWyrm
InfernoWyrm Feb. 27 at 6:25 PM
•@SqueezeSharkie is operating on a whole different level, easily ahead of 90% of the traders on this platform. If you’re not paying attention yet, you’re missing out. Go give him a follow it’s completely free and only takes a second 💎 $SM $BRLS $BYAH $FBRX •,• on watch
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 27 at 12:34 PM
$FBRX RSI: 51.91, MACD: -0.0567 Vol: 1.86, MA20: 30.02, MA50: 28.96 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
porky1963
porky1963 Feb. 26 at 8:04 AM
$FBRX fancy it being a treasure chest then,its got a long way to go but you never know.its holding well with a big volume so lets hang on,crypto takeing a big blow,gold far to expensive,oil stable .inflation steady for now.saveing rates low.if you got in at $5 at its low you realy done well.__
0 · Reply
porky1963
porky1963 Feb. 24 at 11:25 AM
$FBRX guess we are in the UP+DOWN zone.well i have done very well so far and will be here for the long run,there are meetings next month letts be hopefull of good reports i cant see why not.
0 · Reply
InfernoWyrm
InfernoWyrm Feb. 17 at 7:03 PM
$WELL $FBRX $CRI $KVHI \|\|\
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 17 at 12:13 AM
$FBRX Current Stock Price: $31.85 Contracts to trade: $30.0 FBRX Feb 20 2026 Call Entry: $0.50 Exit: $0.88 ROI: 75% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
porky1963
porky1963 Feb. 15 at 3:10 PM
$FBRX good end to the week,can anyone see this at $37 in 6 weeks.
0 · Reply
RebeccaPryor948
RebeccaPryor948 Feb. 11 at 4:04 PM
$FBRX Forte Biosciences; biotech (dermatology); clinical-stage, binary; has faced setbacks, pipeline reset.
0 · Reply
porky1963
porky1963 Feb. 8 at 6:38 PM
$FBRX big swings.its on the edge of a very substancial drop.but just maybe as sometimes does it may indicate a very big rise,just can't make a decision.will hold tight for now.news is due soon just hope its encourageing.
0 · Reply
ForexFlow
ForexFlow Feb. 4 at 3:54 PM
$FBRX is a clinical-stage biotech (Forte Biosciences) developing therapies for dermatological conditions; its pipeline is in clinical trials, representing a high-risk investment.
0 · Reply
G_D_1
G_D_1 Feb. 3 at 12:55 PM
$FBRX Federated Hermes Inc. boosted its holdings in Forte Biosciences, Inc.(NASDAQ:FBRX - Free Report) by 52.5% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,635,380 shares of the company's stock after buying an additional 563,147 shares during the quarter. Federated Hermes Inc. owned 13.16% of Forte Biosciences worth $24,531,000 at the end of the most recent quarter. Perceptive Advisors LLC bought a new stake in shares of Forte Biosciences in the second quarter worth approximately $882,000. Mink Brook Asset Management LLC purchased a new stake in Forte Biosciences in the second quarter worth approximately $503,000. Adage Capital Partners GP L.L.C. purchased a new stake in Forte Biosciences in the second quarter worth approximately $4,310,000. Cable Car Capital LP grew its position in Forte Biosciences by 127.7% in the 2nd quarter.
0 · Reply
G_D_1
G_D_1 Feb. 2 at 7:55 PM
$FBRX Anyone selling ?
1 · Reply
MX1074
MX1074 Jan. 28 at 7:45 PM
$FBRX why -16%?!
0 · Reply
MX1074
MX1074 Jan. 28 at 5:25 PM
$FBRX ...why this drop?!
1 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 21 at 2:39 PM
$FBRX Outstanding article that hits the mark on FBRX's current state. So if you want to refresh your FBRX insights or learn about FBRX from scratch, this is a must read. https://everyticker.com/quote/FBRX/analysis/single-molecule-three-shots-forte-biosciences-bets-everything-on-fb102-s-autoimmune-trifecta-nasdaq-fbrx
0 · Reply
porky1963
porky1963 Jan. 21 at 7:38 AM
$FBRX up soon.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 19 at 2:44 PM
$FBRX RSI: 61.41, MACD: 2.6845 Vol: 3.30, MA20: 27.68, MA50: 21.89 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply